suresh ramalingam, md, fasco, shares results from the flaura trial presented at esmo 2019
Published 4 years ago • 186 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
8:55
suresh ramalingam: osimertinib vs comparator egfr-tki 1st-line in egfrm advanced nsclc (flaura)
-
1:50
researcher comment: positive os data for osimertinib in flaura trial | suresh ramalingam
-
0:59
dr. suresh ramalingam reviews the galaxy-1 trial results
-
6:51
researcher comment: three-year data from checkmate 227 | suresh ramalingam
-
1:01
suresh ramalingam, md, discusses the results of checkmate 227 in advanced nsclc patients
-
8:08
discover the breath of life with dr. a suresh!
-
48:59
coronary dissection dr s selvamani 30th july 2020
-
25:45
best cancer treatment | latest radiotherapy treatment | dr.kamakshi memorial hospitals
-
2:09
dr. ramalingam on flaura trial results in egfr-mutant nsclc
-
1:08
dr. ramalingam on the os results of the flaura trial in egfr-mutant nsclc
-
9:53
esmo 2019: dr. ramalingam discusses confirmatory data in advanced nsclc
-
18:07
2020 winship scientific symposium | suresh ramalingam, md
-
1:43
dr. ramalingam discusses the results of the phase iii revel study in nsclc
-
1:19
dr. ramalingam on the significance of the flaura trial in nsclc
-
1:16
suresh ramalingam, md, offers opinion on optimal sequencing of immunotherapy in nsclc
-
1:05
dr. ramalingam on the activity of osimertinib combinations in nsclc
-
1:43
ramalingam reflects on new role as winship executive director
-
2:34
dr. ramalingam on flaura findings in egfr-mutant nsclc
-
1:40
dr. ramalingam on the role of osimertinib in egfr t790m-positive advanced nsclc
-
2:04
dr. suresh ramalingam on frontline osimertinib data in egfr nsclc
-
6:50
osimertinib: a potential new standard of care for advanced egfr-mutated nsclc | suresh ramalingam
-
18:42
gracecast-134_ca-101_dr. suresh ramalingam: what is a clinical trial?